Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Circadian Technologies chairman Dominique Fisher tops-up shareholding

Circadian Technologies (ASX: CIR) chairman and non executive director Dominique Fisher acquired 15,099 shares at $0.55 per share on September 5 in on market purchases.

The shares were acquired indirectly for a consideration of $8,304.45 through the Stockdale Fisher superannuation fund.

Fisher now holds 17,500 ordinary shares through Merina Pty Ltd and 120,949 through Stockdale Fisher Superannuation Fund.

In the Circadian preliminary report released in August, the company outlined the year ahead, with key events including:

- IND filing in respect of the VGX-100 with the US FDA and subsequent commencement of clinical trials;

- Generation of additional data in animal models on corneal diseases to support development of VGX-100 in corneal disease settings;

- Launch of CUP diagnostic test by Healthscope;

- Development of additional clinical diagnostic tests for the measurement of VEGF-C, VEGF-D and/or VEGFR-3 in patient tissue as diagnostic assays in oncology; and

- Continued expansion of the marketing of our VEGF-D based diagnostic test for LAM, outside of the USA.